Mycoplasma Testing Market: Trends and Developments
The global mycoplasma testing markets growth is
driven by factors such as the growing concerns over cell culture contamination,
growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical
R & D activities and investments.
The global Mycoplasma Testing Market
size is projected to reach USD 1,095 million by 2025
from USD 689 million in 2020, at a CAGR of 9.7%.
Download...
Mycoplasma Testing Market: Geographical Snapshot of the Market
Factors driving the growth of this market
are the rapid growth in the pharmaceutical and biotechnology industries,
R&D investments and government support. Mycoplasma testing is carried out
in the research and production of all biopharmaceutical products. Growth in the
pharmaceutical and biotechnology sector across the globe serves as a direct
driver for associated markets such as mycoplasma testing.
The Mycoplasma
Testing...
Mycoplasma Testing Market worth 943.4 Million USD by 2022
The increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination are expected to drive the growth of this market.
The global market is segmented by product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, services, and instruments....